Human caspase 7 is positively controlled by SREBP-1 and SREBP-2.

Statins are lipid-lowering drugs that may help limit cancer occurrence in humans. They drive blockage of the mevalonate pathway, trigger cancer cell apoptosis in vitro and reduce tumour incidence in animals. We have shown in the present study that statins induced apoptosis in HGT-1 human gastric cancer cells, and this was prevented by intermediates of the cholesterol synthetic pathway. In addition, similarly to what we have reported previously for caspase 2 [Logette, Le Jossic-Corcos, Masson, Solier, Sequeira-Legrand, Dugail, Lemaire-Ewing, Desoche, Solary and Corcos (2005) Mol. Cell. Biol. 25, 9621-9631], caspase 7 may also be induced by statins and is under the positive control of SREBP (sterol-regulatory-element-binding protein)-1 and -2, major activators of cholesterol and fatty acid synthesis genes, in HGT-1 cells. Knocking down these proteins strongly reduced caspase 7 mRNA and protein expression, and chromatin immunoprecipitation analyses showed that the proximal promoter region of the CASP7 gene could bind either SREBP-1 or -2. Strikingly, cells selected to grow in the continuous presence of statins showed increased expression of caspase 7 mRNA and protein, which was maintained in the absence of statins for several weeks, suggesting that high expression of this caspase might participate in adaptation to blunting of the mevalonate pathway in this model. Taken together, our results show that caspase 7, as an SREBP-1/2 target, can be induced under mevalonate-restricting conditions, which might help overcome its shortage.

[1]  E. Alnemri,et al.  Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. , 1995, Cancer research.

[2]  H. Mo,et al.  Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention , 2004, Experimental biology and medicine.

[3]  C. Fielding,et al.  Cholesterol and caveolae: structural and functional relationships. , 2000, Biochimica et biophysica acta.

[4]  L. Corcos,et al.  Caspase-2, a Novel Lipid Sensor under the Control of Sterol Regulatory Element Binding Protein 2 , 2005, Molecular and Cellular Biology.

[5]  Keisuke Kuida,et al.  Caspases 3 and 7: Key Mediators of Mitochondrial Events of Apoptosis , 2006, Science.

[6]  G. Fritz.  HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). , 2005, International journal of oncology.

[7]  M. Seabra.  Membrane association and targeting of prenylated Ras-like GTPases. , 1998, Cellular signalling.

[8]  L. Corcos,et al.  Nonsense-mediated mRNA decay among human caspases: the caspase-2S putative protein is encoded by an extremely short-lived mRNA , 2005, Cell Death and Differentiation.

[9]  T. Narisawa,et al.  Chemopreventive efficacy of low dose of pravastatin, an HMG-CoA reductase inhibitor, on 1,2-dimethylhydrazine-induced colon carcinogenesis in ICR mice. , 1996, The Tohoku journal of experimental medicine.

[10]  M. Katz.  Therapy Insight: potential of statins for cancer chemoprevention and therapy , 2005, Nature Clinical Practice Oncology.

[11]  J.,et al.  Human Acute Myeloid Leukemia Cells Bind to Bone Marrow Stroma Via a Combination of /3-1 and /3-2 Integrin Mechanisms , 2003 .

[12]  L. Corcos,et al.  Identification of a functional DNA binding site for the SREBP-1c transcription factor in the first intron of the human caspase-2 gene. , 2005, Biochimica et biophysica acta.

[13]  Stephen B. Gruber,et al.  Statins and cancer prevention , 2005, Nature Reviews Cancer.

[14]  Keisuke Kuida,et al.  Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.

[15]  Anindya Dutta,et al.  Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells , 2006, Molecular Cancer Therapeutics.

[16]  C. Mantzoros,et al.  Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. , 2008, Atherosclerosis.

[17]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Olivier Hermine,et al.  Vital functions for lethal caspases , 2005, Oncogene.

[19]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[20]  J. Goldstein,et al.  Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. , 2002, Molecular cell.

[21]  M. Minden,et al.  Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells , 2001, Leukemia.

[22]  M. Minden,et al.  HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis , 2002, Leukemia.

[23]  N. Tsuji,et al.  Survivin Down-regulation Plays a Crucial Role in 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitor-induced Apoptosis in Cancer* , 2007, Journal of Biological Chemistry.

[24]  J. Mankovich,et al.  Substrate Specificities of Caspase Family Proteases* , 1997, The Journal of Biological Chemistry.

[25]  E. Sahai,et al.  RHO–GTPases and cancer , 2002, Nature Reviews Cancer.

[26]  R. Gibbs,et al.  Detection of nonsterol isoprenoids by HPLC-MS/MS. , 2008, Analytical biochemistry.

[27]  B. Kaina,et al.  Rho GTPases: promising cellular targets for novel anticancer drugs. , 2006, Current cancer drug targets.

[28]  Christopher Gerner,et al.  Executioner caspase-3 and caspase-7 are functionally distinct proteases , 2008, Proceedings of the National Academy of Sciences.

[29]  Y. Arai,et al.  Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. , 2001, Atherosclerosis.

[30]  C. Laboisse,et al.  Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. , 1982, Cancer research.

[31]  Sung Goo Park,et al.  Mining of caspase-7 substrates using a degradomic approach. , 2008, Molecules and cells.

[32]  P. Auberger,et al.  RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation , 2006, Cell Death and Differentiation.

[33]  Ju-yong Wang,et al.  Downregulation of survivin expression and elevation of caspase-3 activity involved in pitavastatin-induced HepG 2 cell apoptosis. , 2007, Oncology reports.

[34]  Roger J. Daly,et al.  The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis , 2004, Journal of Mammary Gland Biology and Neoplasia.

[35]  Jayoung Kim,et al.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. , 2005, The Journal of clinical investigation.

[36]  Á. Pascual,et al.  3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. , 2002, Atherosclerosis.

[37]  D Tabor,et al.  Regulation of gene expression by SREBP and SCAP. , 2000, Biochimica et biophysica acta.

[38]  F. Dammacco,et al.  Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells. , 2005, Carcinogenesis.